Hostname: page-component-84b7d79bbc-4hvwz Total loading time: 0 Render date: 2024-08-03T07:39:18.888Z Has data issue: false hasContentIssue false
  • English
  • Français

HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT FOR THE ADOPTION OF INNOVATIVE MEDICAL DEVICES WITHIN FRENCH HOSPITALS: OPPORTUNITIES AND CHALLENGES FOR INDUSTRY

Published online by Cambridge University Press:  05 June 2017

Camille Dutot ,
Grégoire Mercier ,
Isabelle Borget ,
Côme de Sauvebeuf  and
Nicolas Martelli
Camille Dutot
Affiliation:
Unité de recherche médico-économique, CHU de Montpellier
Grégoire Mercier
Affiliation:
Unité de recherche médico-économique, CHU de Montpellier
Isabelle Borget
Affiliation:
University Paris-Sud, GRADES, Faculty of Pharmacy Department of Epidemiology and Biostatistic, Gustave Roussy Institute
Côme de Sauvebeuf
Affiliation:
Biodimed Conseils
Nicolas Martelli
Affiliation:
University Paris-Sud, GRADES, Faculty of Pharmacy Pharmacy Department, Georges Pompidou European Hospital, Assistance Publique – Hôpitaux de Parisnicolas.martelli@aphp.fr
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: Within French university hospitals, some internal committees are in charge of conducting hospital-based health technology assessment (Hb-HTA) to support managerial decisions regarding the adoption of innovations. For manufacturers, hospitals are usually the entry point for new and innovative medical devices, which cannot be accessed without the Hb-HTA committees' approval. Thus, the main objective of this pilot survey was to explore manufacturers’ insights into Hb-HTA processes.

Methods: A two-step pilot survey was conducted in 2014. First, semi-structured phone interviews were carried out to capture manufacturers' feedback on the Hb-HTA procedure. Second, a prospective and iterative questionnaire designed to explore manufacturers’ market access strategies was administered.

Results: Eight manufacturers from the medical device industry completed the retrospective phone interviews, and five of them participated in the prospective survey. According to the overall feedback, the Hb-HTA process timeline and transparency are major issues, and the expectations of internal committees, especially in terms of clinical evidence, remain difficult to understand. However, despite this and due to the complexity of reimbursement processes at the national level, manufacturers are increasingly considering hospital adoption through Hb-HTA submission as a viable market access and coverage opportunity.

Conclusions: Our study reaffirms the primary role of hospitals in the diffusion of innovative medical devices. However, to ensure efficient and broad access to innovation, cooperation between local and national HTA bodies is critical and should be promoted.

Keywords

Hospital-based HTAMedical deviceInnovationMarket access
Type
Policies
Information
International Journal of Technology Assessment in Health Care , Volume 33 , Issue 2 , 2017 , pp. 297 - 302
Copyright
Copyright © Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Gagnon, MP. Hospital-based health technology assessment: Developments to date. Pharmacoeconomics. 2014;32:819–824.Google Scholar
2. Scheller-Kreinsen, D, Quentin, W, Busse, R. DRG-based hospital payment systems and technological innovation in 12 European countries. Value Health. 2011;14:1166–1172.Google Scholar
3. Bodeau-Livinec, F, Simon, E, Montagnier-Petrissans, C, Joël, ME, Féry-Lemonnier, E. Impact of CEDIT recommendations: An example of health technology assessment in a hospital network. Int J Technol Assess Health Care. 2006;22:161–168.Google Scholar
4. Hailey, D, Menon, D. A short history of INAHTA. International network of agencies for health technology assessment. Int J Technol Assess Health Care. 1999;15:236–242.Google Scholar
5. Beaussier, H, Junot, H, Lancrenon, S, Faure, P. Evaluation des DM innovants au sein des hôpitaux: avec quelles données cliniques? Ann Pharm Fr. 2012;70:35–45.Google Scholar
6. Martelli, N, Billaux, M, Borget, I, et al. Introduction of innovative medical devices at French university hospitals: An overview of hospital-based health technology assessment initiatives. Int J Technol Assess Health Care. 2015;31:12–18.CrossRefGoogle ScholarPubMed
7. Boudard, A, Martelli, N, Prognon, P, Pineau, J. Clinical studies of innovative medical devices: What level of evidence for hospital-based health technology assessment? J Eval Clin Pract. 2013;19:697–702.CrossRefGoogle ScholarPubMed
8. Pôle Interministériel de Prospective et d'Anticipation de Mutations Economiques (PIPAME); Dispositifs médicaux: diagnostic et potentialités de développement de la filière française dans la concurrence internationale. Ministère de l'Economie, des Finances et de l'Industrie. 2011. http://www.entreprises.gouv.fr/files/files/directions_services/etudes-et-statistiques/prospective/dispositifs-medicaux/etude-dispositifs-medicaux.pdf (accessed August 2016).Google Scholar
9. Creswell, JW, Klassen, AC, Plano Clark, VL, et al. Best practices for mixed methods research in the health sciences. National Institutes of Health. 2011. https://obssr.od.nih.gov/wp-content/uploads/2016/02/Best_Practices_for_Mixed_Methods_Research.pdf (accessed August 2016).Google Scholar
10. Chaves, S, Mazzon, JA, de Souza, CA. Proposition of a method to measure rankings using the Delphi technique. Future SRJ. 2012;4:52–75.Google Scholar
11. Schmidt, RC. Managing Delphi surveys using non parametric statistical techniques. Decis Sci J. 1997;28:763–774.Google Scholar
12. Vestergaard, M, Ehlers, L, Kidholm, K, et al. Introduction to mini-HTA - a management and decision tool for the hospital service. Copenhagen: Danish Centre for Evaluation and Health Technology Assessment; 2005.Google Scholar
13. Sampietro-Colom, L, Lach, K, Cicchetti, A, et al. The AdHopHTA Handbook: A handbook of hospital-based Health Technology Assessment (HB-HTA). Public deliverable; The AdHopHTA Project (FP7/2007-13 grant agreement nr 305018); 2015. http://www.adhophta.eu/handbook (accessed August 2016).Google Scholar
14. Medical technology recommendations on stakeholders’ involvement in the EU HTA cooperation at strategic and operation levels. Position paper. 2016. http://ec.europa.eu/health/technology_assessment/docs/ev_20160520_co01_en.pdf (accessed August 2016).Google Scholar
15. Morel, A, Kiour, A, Garcia, A. Evolution et maîtrise de la dépense des dispositifs médicaux. Paris: Inspection Générale des Affaires Sociales; 2010.Google Scholar
16. Sampietro-Colom, L, Morilla-Bachs, I, Gutierrez-Moreno, S, Gallo, P. Development and test of a decision support tool for hospital health technology assessment. Int J Technol Assess Health Care. 2012;28: 460–465.Google Scholar
Supplementary material: File

Dutot supplementary material

Dutot supplementary material 1

Download Dutot supplementary material(File)
File 18.6 KB